Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts RemSense Capital Raising August 4, 2025 Tech 5: Tesla and Samsung Strike Deal, Palo Alto to Acquire CyberArk August 3, 2025 Anglo American’s Losses Widen with Diamond Slump, Trade Tensions Mounting August 2, 2025